The British journal of ophthalmology
-
Multicenter Study Comparative Study
Adalimumab for the treatment of refractory active and inactive non-infectious uveitis.
To compare the efficacy of adalimumab in eyes with active and inactive non-infectious uveitis in the real-world setting. ⋯ Adalimumab appears to reduce the corticosteroid burden in active and inactive non-infectious uveitis in the real-world setting. Inflammatory activity at the time of adalimumab commencement may determine long-term treatment success.